Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1467 of 5804
-
New HIV vaccine shows promise in early human trial
⭐️ VACCINE ⭐️ CompletedThis is an open-label Phase 1 study to examine the safety and immunogenicity of the CH505 TF chTrimer vaccine with 3M-052-AF +/- Alum adjuvant in healthy adults. The primary hypothesis is that the CH505 TF chTrimer will expand CH103-like B-cell precursors. HVTN 300 Part A examin…
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:07 UTC
-
Off-the-Shelf immune cells take on tough lymphoma
Disease control CompletedACE1831 is an off-the-shelf, allogeneic gamma delta T (gdT) cell therapy derived from healthy donors, that is under investigation for the treatment of CD20-expressing B-cell malignancies. The ACE1831-001 study is an open-label, Phase I, first-in-human (FIH) study that aims to ev…
Phase: PHASE1 • Sponsor: Acepodia Biotech, Inc. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New drug combo takes on recurrent brain tumors
Disease control OngoingVorasidenib in combination with pembrolizumab in participants with recurrent or progressive isocitrate dehydrogenase-1 (IDH-1) mutant Glioma.
Phase: PHASE1 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Brain camera could spot which cells are causing Alzheimer's inflammation
Knowledge-focused Recruiting nowInflammation occurs in many brain diseases including Alzheimer's disease. In Alzheimer's disease, an abnormal protein called amyloid starts accumulating decades before the start of forgetfulness. However, scientists have reported that inflammation but not amyloid is linked to for…
Sponsor: The Methodist Hospital Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Heart rehab may boost stroke recovery, new study hopes to prove
Disease control Recruiting nowThis study examines the effectiveness of the cardiac rehabilitation program for stroke patients. The study will examine if patients with stroke, who receive cardiac rehabilitation in addition to their standard of care treatments, demonstrate improved recovery of function. It will…
Phase: NA • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Kids' blood tests could help parents kick the habit
Disease control CompletedThis randomized controlled trial will test whether adding biomarker measurement and informed outreach for tobacco smoke exposure as part of routine practice increases identification and improves treatment, effectiveness, and sustainability of a parental tobacco control interventi…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Intermittent fasting tested to ease radiation side effects in cancer patients
Symptom relief OngoingThis phase II trial studies how well time-restricted eating works in reducing side effects of radiation or chemoradiation side effects when compared to nutritional counseling among patients with prostate, cervical, and rectal cancers. Time-restricted eating, also called short ter…
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Twin pregnancy breakthrough? stitch plus hormone may stop preterm birth
Disease control CompletedTwin pregnancies face a high risk of complications, most notably preterm birth (delivery before 37 weeks), which is a major cause of infant death and illness globally. For women carrying twins who are identified as having a short cervical length (cervix measuring 25 millimeters o…
Phase: PHASE2 • Sponsor: Benha University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
CRISPR's diabetes cell therapy trial ends early
Disease control TerminatedThis is an open-label, multicenter, Phase 1 study evaluating the Safety, Tolerability, and Efficacy of VCTX211 Combination Product in Subjects with T1D
Phase: PHASE1 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
MS crystal ball: new biomarkers aim to predict disability before it strikes
Knowledge-focused OngoingMultiple sclerosis (MS) is the most common acquired neurological disease leading to disability in young adults. MS often leads to the development of a physical and/or cognitive impairment that disables patients in their daily lives. Early use of disease modifying treatments for p…
Sponsor: EDMUS Foundation • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
New drug hope for kids with rare lung disease
Disease control Recruiting nowThe primary objectives of the study are to evaluate the safety and tolerability, and pharmacokinetics (PK) of sotatercept over 24 weeks of treatment in children ≥1 to \<18 years of age with PAH World Health Organization (WHO) Group 1 on standard of care (SoC). There is no formal …
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Lab breakthrough: new method supercharges immune cells against Kids' cancers
Knowledge-focused Recruiting nowPediatric solid tumors exhibit a low mutational burden, limited availability of neoantigens, and poor infiltration of tumor-infiltrating lymphocytes (TILs) within the tumor microenvironment (TME), characteristics that reduce the effectiveness of immunotherapies in children. Howev…
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Weight loss drug showdown: semaglutide vs. the rest in Real-World workers
Disease control CompletedThe purpose of this post approval pragmatic clinical study is to see how well semaglutide lowers body weight compared to other medication on the market used to treat obesity, across three US-based employers. These employers represent employees of diverse demography and job functi…
Phase: PHASE4 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New AI-Powered swab test aims to spot viruses in minutes
Diagnosis Recruiting nowCurrent virus detection methods often take significant time or can be limited in sensitivity, specificity or cost. There is therefore a need for diagnostic methods that are simple to use, sensitive, rapid and inexpensive. This is a proof of concept study to determine whether the…
Sponsor: Portsmouth Hospitals NHS Trust • Aim: Diagnosis
Last updated Jul 02, 2026 00:00 UTC
-
Could a cancer drug regrow hair in rare autoimmune disease?
Disease control Recruiting nowBackground: Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) is a problem of the immune system. In people with APECED, the immune system makes a mistake and attacks the body. Some people with APECED have a type of hair loss called alopecia areata (AA). No …
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could a blood draw help men with no sperm become fathers?
Disease control Recruiting nowInvestigate the effect of intratesticular injection of autologous platelet rich plasma (PRP) on sperm retrieval rates and IVF outcomes in infertile men who already underwent a negative sperm retrieval. Currently, there is no alternative treatment after failed TESE. Prior series s…
Phase: NA • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New drug aims to keep rare nerve disease in check long-term
Disease control OngoingThis trial is an extension of the antecedent trial ARGX-117-2002. It is a multicenter trial that has been designed to evaluate the long-term safety and tolerability, efficacy, immunogenicity, Pharmacokinetics (PK), and Pharmacodynamics (PD) of ARGX-117 Intravenously (IV) in adult…
Phase: PHASE2 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Could a simple pill prevent a painful complication after endoscopy?
Prevention Recruiting nowThis research is being done to see if using oral tacrolimus before endoscopy, can prevent pancreatitis that may occur after ERCP (a type of gastrointestinal endoscopy).
Phase: PHASE3 • Sponsor: Johns Hopkins University • Aim: Prevention
Last updated Jun 27, 2026 08:03 UTC
-
New scan could spot endometriosis without surgery
Diagnosis Recruiting nowPurpose: The aim of this study is to assess the sensitivity and specificity of FFNP PET/MRI for diagnosis of endometriosis. Participants: A total of 24 participants will be recruited from individuals with clinically suspected endometriosis. Procedures (methods): This is a prosp…
Phase: PHASE2 • Sponsor: University of North Carolina, Chapel Hill • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC
-
Virtual reality goggles ease pain for kids with cancer
Symptom relief Recruiting nowDOREVI is a monocentric randomized controlled study that will evaluate the efficacy of virtual reality helmets for pain prevention during invasive care on 78 oncologic pediatric patients. Two groups of children (between 6 and 11 and between 12 and 18 years old) will be randomized…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de la Réunion • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC